Project Grant R01NS148151
- Federal Grant Award Summary Virginia Polytechnic Institute & State University (Virginia Tech) received a $452,769 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 11, 2025, to conduct research on the impact of BDGR-49 treatment on Venezuelan Equine Encephalitis Virus (VEEV) induced neurological sequelae. The research addresses a critical public health gap by...
- Federal Project Grant Award Summary The University of Arizona received a $711,256 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective June 1, 2026 through May 31, 2031. This research initiative investigates the mechanistic basis of how neurons counteract Toxoplasma gondii infection while mitigating immune pathology in the central nervous...
- Federal Grant Award Summary Virginia Polytechnic Institute & State University (Virginia Tech) received a $414,482 Project Grant award from the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 24, 2025, with a completion date of June 30, 2027. The research focuses on developing an improved oncolytic virus therapeutic to treat glioblastoma, an aggressive brain cancer with poor prognosis. The project aims to...
- Federal Grant Award Summary Virginia Polytechnic Institute & State University (Virginia Tech) received a $375,392 Project Grant from the Fogarty International Center (FIC) under the International Research and Research Training program (CFDA 93.989) awarded on September 9, 2025, with completion targeted for August 31, 2027. The project, titled "Leveraging Mexican Millipede Secretions as Neuromodulators," focuses on developing natural product-based treatments for neurological pain...
- Federal Grant Award Summary Virginia Polytechnic Institute & State University (Virginia Tech) received a $437,541 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 2, 2026, through January 31, 2028. The award supports the discovery and development of antisense therapeutic candidates targeting Clostridioides difficile infection (CDI), a leading cause of nosocomial...
- Federal Project Grant Award Summary Virginia Polytechnic Institute & State University (Virginia Tech) received a $422,355 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded July 23, 2025, with completion targeted for June 30, 2027. The grant funds mechanistic and structural studies examining the signaling histidine kinase GacS from Pseudomonas aeruginosa, a nosocomial...
- Federal Grant Award Summary Virginia Polytechnic Institute & State University (Virginia Tech) received a $1.17M Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), effective July 1, 2025, through April 30, 2030. The project, titled "Thalamo-Hippocampal Interplay in Early Life Trauma-Induced Aggression," will conduct basic neuroscience research to elucidate the neural circuit mechanisms linking early life...
- Federal Grant Award Summary Virginia Polytechnic Institute & State University (Virginia Tech) received a $191,163 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 5, 2026 through January 31, 2028. The award supports research investigating the transmission dynamics and pathogenesis of contemporary Mayaro virus (MAYV) strains, with particular focus on...
- Federal Grant Award Summary Virginia Polytechnic Institute & State University (Virginia Tech) received a $422,314 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective March 1, 2026 through January 31, 2031. This award supports fundamental research investigating specialized adaptations in flagellar-driven motility and chemosensory systems in the alpha-proteobacterium Sinorhizobium...
- Federal Project Grant Award Summary Virginia Polytechnic Institute & State University received a $322,000 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866) for a two-year period from February 1, 2026 through January 31, 2028. The award supports research investigating mitochondria and synapse crosstalk in Alzheimer's disease (AD) circuit vulnerability, with the research to be conducted at Virginia Tech's Roanoke, Virginia facility. The project...
Virginia Polytechnic Institute & State University (Virginia Tech) received a $392,338 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective May 15, 2026, with a completion date of April 30, 2031. The research project investigates synaptic signaling mechanisms in Toxoplasma-infected brains, specifically examining how the protozoan parasite Toxoplasma gondii causes seizures and neurological complications when reactivated in immunocompromised patients and fetuses. The research addresses a critical public health concern, as approximately one-third of the global population carries latent T. gondii infections that can become life-threatening when the host immune system fails. The project delivers fundamental neuroscience research outputs through two primary research aims: (Aim 1) studying how the complement system recognizes inhibitory perisomatic synapses for elimination during toxoplasmic encephalitis, and (Aim 2) identifying neuronal factors that recruit microglia to remove these critical inhibitory synapses. By elucidating the mechanisms linking pathogen-host interactions to seizure development, this research will generate novel insights into seizure pathophysiology and inform future therapeutic interventions for patients with toxoplasmosis-related neurological disease.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $392.3k | 5/7/26 |